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Abstract: Known as nerve sheath myxoma too, neurothekeoma are benign tumors, 
usually arise in the skin of the head, neck region and upper extremities, in young females. 
Cerebral neurothekeoma are very rare, a few cases were already described in the 
parasellar area, in the middle cranial and posterior fossa. We present a petro-clival 
neurotekoma.  A 78-year-old male was admitted for two years left fronto-temporal 
headache completed in the last 6 months with left trigeminal V1 neuralgia, left facial 
hypoesthesia, diplopia, swallowing disorders for liquid foods, balance disorders. From 
his medical records we noticed: stage 2 chronic kidney disease, hypertension, prostate 
adenoma, dyslipidemia hypercholesterolemia. The MRI showed a macronodular petro-
clival mass in hiper T2, hipo T1, flair iso signal; normal cerebral angiography. The 
patient was operated on using a left retrosigmoid, retromastoidian approach. A 4/3/3 cm 
tumor, gray, encapsulated, soft consistency, partially cystic, less bleeding, attached to 
the dura, displacing the basilar artery and brain stem controlateral, encasing the 
trigeminal nerve. The tumor was totally removed with a good postop evolution. Six 
months follow up he had no more facial pain, but only persistant left facial hypoesthesia. 
Histologically the tumor had lobular appearance with spindle or stellate cells embedded 
in abundant myxoid background. The tumor cells were diffusely positive for S100, 
PGP9.5’, CD 34” positive in vessels, Ki67’positive in 5%.  Cranial MRI performed one 
month after surgery did not show any residual tumor. Also known as nerve sheath 
myxomas, neurothekoma are rare benign tumors. For intracranial neurothekoma surgical 
indication is mandatory 
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Introduction 
Neurothekeoma is a benign, predominantly 
cutaneous tumor, of probable nerve sheath 
origin (1-7), quite common, presented as a 
solitary nodule in the head (5), oral cavity (7), 
hypopharynx (8), tongue (9), maxilla (10), 
breast (11), neck shoulders or upper limbs 
(12), peripheral nerve - median nerve (13), 
spinal intradural (6)(14)(15), even cervical - 
intramedullary (14). The intracranial 
localization was reported in only few cases 
(16)(17): disposed in the pituitary area (18), 
medium (19) and posterior fossa (20)(21): 
cerebelopontine angle (22), pons (23). After 
our knowledge the current report is first in 
world literature with neurothekeoma located 
petro-clival.  
Case Report 
A 78-year-old male was admitted in our 
clinic for two years left fronto-temporal 
headache completed in the last 6 months with 
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left trigeminal V1 neuralgia (cvasi constant, 
without benefit from analgesics), left facial 
hypoesthesia, diplopia, swallowing disorders 
for liquid foods, balance disorders. From his 
medical records we noticed: stage 2 chronic 
kidney disease, hypertension, prostate 
adenoma, dyslipidemia, 
hypercholesterolemia. Biochemical 
investigations showed too: a slight nitrate 
retention: urea 74 mg/dl, creatinina 1.7 mg/dl 
and slight hypopotasemia 3,4 mmol/l.  
Axial, coronal, and sagittal MRIs of the 
head displayed: an extranevraxial petro-clival 
mass, well delineated, with heterogeneous 
tissue component with peripheral cystic 
component, hypointense on T1-weighted 
images, hyperintense on T2-weighted images 
with heterogeneous enhancement following 
contrast agent administration, measuring 33 
mm transverse Ø, 23 mm antero-posterior Ø 
and 37 mm cranio – caudal Ø,  with distortion 
of the brain stem, left nerves VII, VI, III; also  
the adjacent arteries: basilar trunk, superior 
left cerebellar artery and posterior cerebral 
artery (Figure 1). Important periventricular 
demyelinating lesions and cerebral atrophy 
associated, dilatation of ventricular system 
with periventricular lucency. 
 
  
A                                          B 
  
C                                      D 
Figure 1 - Preoperatory MRI: A-C axial, D coronal 
images showing the extranevraxial petro-clival tumor 
mass, with heterogeneous tissue component and 
peripheral cystic component, distorting the brain 
stem, left nerves VII, VI, III, the adjacent arteries: 
basilar trunk, superior left cerebellar artery and 
posterior cerebral artery 
 
Using a left retromastoidian, 
retrosigmoidian approach an encapsulated, 
gray tumor was discovered in the petro-clival 
area. This tumor has soft consistency, partially 
cystic, mixed with areas of fibrotic tissue, less 
bleeding, attached to the dura, encasing 
trigeminal nerve, displacing the basilar artery 
and brain stem controlateral. The tumor was 
totally removed. Postoperatory evolution was 
uneventfull; six months follow up he had no 
more facial pain, but only persistant left facial 
hypoesthesia. 
 Histological and immunohistochemical 
staining was performed. Histologically the 
tumor was encapsulated by a thin fibrous 
connective tissue and composed by fusiform 
and stellate cells, with loose, pale, myxoid 
stroma; arranged in ovoid lobules of varying 
sizes separated by fibrous septae; rare high cell 
density areas presenting cells with central 
monomorphic nuclei showing spindle-shaped 
extensions and clear peripheral cytoplasm 
were observed. No mitosis and mild nuclear 
pleomorphism was noted (Figure 2). 
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Figure 2 - A. col. H.E. 10 x 4 overview image: low 
density cells, arranged in lobules of varying sizes, 
separated from conjunctival vascular septa; fusiform 
and stellate monomorphic nuclei with schwanoid 
aspect 
B. col H.E. 10 x 10: tumor cells lobules arranged in a 
lax, pale, myxoid background, separated by 
conjunctival vascular septa with inflammatory 
elements                                                                  
C. col H.E. 10 x 20 : lax, mixoid, peripheric cellular 
tumoral areas and central tumoral area with Antoni B 
schwannoma type appearance                           
D.col H.E. 10 x 40 detail: “schwanoid” tumoral area 
On immunohistochemical studies diffuse 
positive staining of the cells with S-100 and 
vimentin was observed. Glial fibrillary acidic 
protein (GFAP), epithelial membrane antigen 
(EMA), cytokeratin antibody (MNF116) and 
neurokinin 1 (NK1) were negative. CD34 was 
positive in vessels and Ki67 was positive in 
5% of cases. These histological and 
immunohistochemical findings are considered 
characteristic of neurothekeoma, with low 
relevant aggression proliferation (Figure 3) 
After operation facial pain progressively 
diminuished; balance disorder and swallowing 
disorders for liquid foods disappear. A 5 day 
postop MRI demonstrate important reduction 
of mass effect on brain stem, no parenchimal 
tumor mass anteriorly described (Figure 4)  
Six months follow up he had only persistent 
left facial hypoesthesia. No chemotherapy or 
radiation was used in this case. 
 
 
A 
 
B 
Figure 3 - Immunohistochemichal stains: 
A. S100, 4 X 10: diffuse positivity in tumoral cells 
and negativity in vascular structures 
B. GFAP, 4 X 10: negative, proving no glial origin 
  
A                                  B 
Figure 4 - Postoperatory MRI: axial and sagital T1 
showing important reduction of mass effect on brain 
stem, without tumoral remnants 
Discussion 
Neurothekeoma is a benign, predominantly 
cutaneous neoplasm of presumed neural 
sheath origin, usually arising in the skin of the 
scalp, nose, orbital region especially eyelids, 
cheeks, paranasal sinuses, oral mucosa 
hypopharynx, chin, neck, the upper trunk, 
breast also in spinal topography of children 
and young adults as a flesh-colored solitary 
nodules solitary nodule with overlying 
erythema on cutaneous examination. The 
lesions range in size from about 0.5 cm to most 
commonly less than 2 cm in diameter; mean 
age of 25 years – but may occur at any age, 
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with a female preponderance, the male to 
female ratio is approximately 1:4,3 (1)(3)(17).  
This tumor was initially described by 
Harkin and Reed (2) in 1969 by the name 
“nerve sheath myxoma”. In 1980, Gallager 
and Helwig (3) termed the lesion 
neurothekeoma (greek: theke, sheath) to 
connote the histologic nested appearance in 
order to reflect the presumed origin of the 
lesion from nerve sheath; cells are usually 
spindle-shaped and arranged in fascicular or 
whorled patterns (5)(17). Epithelioid cells 
have been observed in these tumors. Several 
names were used for this tumor: “bizarre 
cutaneous neurofibroma”, “plexiform 
myxoma”, “myxoma of nerve sheath”, 
“pacinian neurofibroma”, cutaneous lobular 
neuromyxoma, perineurial myxoma reflecting 
the uncertainty regarding their true 
“histogenesis” or precise line of differentiation 
(15)(16)(22). 
Histologically neurothekoma on gross 
examination appear as dermal tumors 
commonly measuring 0.5 to 2 cm in dimension 
(2)(5). On microscopy (22)(24) 
neurothekomas could be:  
- myxoid - generally agreed of neural 
origin, displaing a lobulated, non-encapsulated 
but well-circumscribed proliferation of 
stellate, spindle-shaped and epithelioid cells – 
less commonly situated in multiple, closely 
spaced nodules of varying sizes, with abundant 
eosinophilic, finely granular cytoplasm, 
embedded within a myxoid stroma. Due to the 
large amount of myxoid stroma separating the 
cells, the tumor cells are said to display a 
random growth pattern. 
- cellular subtype: first described by 
Barnhill in 1990 (26), contains little myxoid 
material, hypercellular nests and fascicles of 
epithelioid cells with vesicular nuclei 
containing scant myxoid stroma, also sclerotic 
collagen, poorly circumscribed, no 
immunoreactivity to the S-100 protein (5). The 
nodules of cellular neurothekeoma are smaller 
than those of the myxoid subtype. Several 
variants of cellular neurothekoma are 
described: atypical or desmoplastic with low 
mitotic activity, with perineural and vascular 
invasion, osteoclastic giant cells in a minority 
of cases, neurothekoma mimicking 
nevomelanocytic tumors (2)(3)(5)(17)(26) are 
described. 
- intermediate subtype demonstrate a 
whorled growth pattern with features of both 
cellular and myxoid variants 
The etiology of neurothekeoma arising in 
the parenchyma remains enigmatic (5)(25): by 
neural differentiation – see myxoid areas 
similar to classic myxoid neurothekeoma, by 
smooth muscle differentiation - 
myofibroblastic or by the epithelioid variant of 
dermatofibroma represented by cellular 
neurothekeoma. Since the time of their first 
description, it has been reported that the 
probable cell of origin could be the Schwann 
cell innervating the blood vessels 
(2)(3)(17)(22). Although they are similar in 
appearance and in behavior, neurothekeoma 
and nerve sheath myxoma are likely not of 
nerve sheath origin, as implied by the term and 
not related histogenetically. Anothers possible 
origins could be: perineural cell of the nerves 
in the dura mater, around the blood vessels or 
by extreme differentiation of the precursor 
pluripotent cell resting inside the brain 
parenchyma under suitable conditions to the 
schwannian phenotype (31). 
Neurothekeoma immunohistochemistry 
(24)(27)(28) demonstrates: 
-for myxoid subtype: diffuse S100 protein 
and glial fibrillary acidic protein (GFAP) 
immunoreactivity, supporting its schwannian 
differentiation. The myxomatous type 
generates large amounts of myxoid matrix and 
is typically immunoreactive to the S-100 
protein (27). 
-for cellular subtype: focal positivity for 
S100 protein in a minority cases (5), NK1/C3, 
an antibody that stains neuroectodermal tissue 
and PGP9.5, a broad marker for 
neuroectodermally derived tumors 
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demonstrates positivity; but these two markers 
are not specific; smooth muscle actin (SMA) 
& neuron-specific enolase (NSE) have shown 
positivity. A very high sensitivity has S100 A6 
is a member of the S100 protein family, but 
with low specificity. 
Neurothekeomas can also show 
immunoreactivity to vimentin. 
The tumor in our case was encapsulated, 
composed by fusiform and stellate cells, with 
loose, pale, myxoid stroma; arranged in ovoid 
lobules of varying sizes separated by fibrous 
septae, no mitosis and mild nuclear 
pleomorphism was seen, rare high cell density 
areas presenting cells with central 
monomorphic nuclei showing spindle-shaped 
extensions and clear peripheral cytoplasm.  
The immunohistochemichal findings in our 
case shows: diffuse positive staining of the 
cells with S-100 and vimentin and negative 
glial fibrillary acidic protein (GFAP), 
epithelial membrane antigen (EMA), 
cytokeratin antibody (MNF116) and 
neurokinin 1 (NK1). CD34 was positive in 
vessels and Ki67 was positive in 5% of cases. 
The histological and immunohistochemical 
findings are considered characteristic of 
neurothekeoma, with low relevant aggression 
proliferation (fig. 3). 
A rare variant of this neoplasm constitute 
the atypical cellular neurothekeoma (29) seen 
occasionally, starting from cellular and 
intermediate subtype. For this variant, large 
tumor size (up to 6 cm), atypical histologic 
features: cellular atypia (rounded or ovoid 
nucleus with abundant cytoplasm), few 
individual cell necroses, high mitotic rate 
ranged from 8 to 12 per 10 high-powered 
fields, marked cytologic pleomorphism 
correlates with local invasion: deep 
penetration extending into skeletal muscle 
and/or adipose infiltration, diffusely 
infiltrative borders, vascular invasion, possible 
recurrence if surgical excision of these lesions 
was incomplete, without metastases. 
There are few reports referring to 
neurothekeomas with an intracranial location 
(16)(30)(31): disposed in the pituitary area 
(17), middle cranial fossa (18) and posterior 
fossa (20)(21): cerebelopontine angle (22), 
pons (23). The most common type of 
intracranial neurothekeoma is myxoid; 
characterized by hypocellularity, with small 
spindle or stellate cells loosely arranged in 
abundant mucinous stroma. On 
immunohistochemical staining, the tumor 
cells are typically immunoreactive to the S-
100 protein (1-3,8), nerve growth factor 
receptor (p75NGFR), collagen type IV, CD34, 
glial fibrillary acidic protein, and CD. 
In our case, the neurothekeoma was 
hypointense in T1-weighted images and 
hyperintense in T2-weighted images using 
MRI, similar to the MRI findings of a 
previously published neurothekeoma cases, 
with heterogeneous enhancement following 
gadolinium administration, of the peripheral 
portions and nonhomogeneous uptake in the 
central areas, which corresponded 
histologically to the vascular capsule and the 
myxoid center (2)(16) 
In general surgery are beneficial, gross 
total resection is recommended and appears to 
be the definitive therapy (16)(31), without 
causing neurologic deficit for the patient; 
incomplete excision of neurothekeomas may 
lead to recurrence and local invasion (5)(17). 
Even if the trigeminal nerve was encased in the 
tumor – see our case, the resection was easy, 
without causing neurologic deficit for the 
patient.  
Because both myxoid and cellular types of 
neurothekeomas are benign; there are no  
reported cases of metastases and the lesion 
does not need postoperative radiotherapy (31) 
or adjuvant chemotherapy (21). Follow-up for 
surveillance is necessary to detect recurrence 
in casese of incomplete intracerebral 
neurothekeomas excision (16)(22). 
Differential diagnosis in neurothekeomas 
should be made with (16)(18)(20)(22)(31):  
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-epidermal inclusion cysts, intradermal 
Spitz nevi, smooth muscle tumors, 
fibrohistiocytic tumors lipomas, 
pilomatrixomas, dermatofibromas, 
melanomas – sometimes difficult to be 
distinguish histologically from cellular 
neurothekeoma (melanocytic tumor are S100 
positive, while cellular neurothekeoma are 
S100 negative), carcinomas 
-schwannomas - well-circumscribed, 
sometimes cystic and often heterogeneously 
enhancing mass on MRI, usually seen in the 
oculomotor and the ambient cistern (32). The 
myxoid type of neurothekeoma may resemble 
to schwannoma, but lacks Verocay bodies and 
the Antoni A, B arrangement seen in 
schwannoma. 
-meningiomas - typically isointense, 
contrast-enhancing extraaxial tumor with 
“dural tail”, surrounding the dural perimeter of 
the mass on MRI,  
-epidermoid - hyperintense lesion.  
-gliomas, meningiomas, sarcomas showing 
myxoid degeneration also cardiac myxomas 
metastasizing to the brain and soft tissue 
myxomas penetrating the skull 
-spinal myxoid neurofibroma (6)(14) 
-perineuromas are rare tumours which 
appear myxomatous, but no lobulation is 
noted, composed exclusively of perineural 
cells (22) 
Conclusion 
Intracranial neurothekeoma is a a benign, 
rare tumor, similar to the cutaneous type, with 
a distinctive clinic and histopathologic entity, 
unlikely to recur if totally excised, even in a  
petro-clival topography. 
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